• Home
  • Editorial Board
  • Articles
    • Editorials
    • Guest Articles
  • News
    • Featured
    • Biotech News
  • Interviews
    • Interviews – Academia
    • Interviews – Industry
  • Issues – Archives
  • Subscribe
  • Contact
Facebook Twitter Instagram
Trending
  • CDC Boss kicked out in RFK Jr.’s War on Corruption in pharma and healthcare
  • Prof. Rajeev Varshney FRS, now joins Australian Academy of Science
  • Dr. Cyrus S. Poonawalla, SII unveiled the newly built School for Hearing Impaired in Pune
  • AdFalciVax: ICMR’s New Malaria Vaccine: Hope or Premature Hype?”
  • The Sudden Deaths and COVID Vaccines: A Critical Analysis of the ICMR and AIIMS Studies
  • KGMU Scandal: Dr. Tulika Chandra Exposed in Crore Rupee Forgery and Scam
  • Zydus to launch market-specific dosage variants of Semaglutide, MD says
  • Biocon Biologics Launches Nepexto, Etanercept Biosimilar in Australia
Wednesday, October 1
Facebook Twitter Instagram LinkedIn
Biotech Express
  • Home
  • Editorial Board
  • Articles
    • Editorials
    • Guest Articles
  • News
    • Featured
    • Biotech News
  • Interviews
    1. Interviews – Academia
    2. Interviews – Industry
    Featured
    04/01/20241

    Interview: Reach to common man is the heart and soul of India International Science Festival- Dr. Arvind C Ranade Chief Coordinator, IISF- 2023

    Recent
    04/01/2024

    Interview: Reach to common man is the heart and soul of India International Science Festival- Dr. Arvind C Ranade Chief Coordinator, IISF- 2023

    22/05/2023

    Prof Rajeev Varshney becomes the 4th Indian Agricultural Scientist to be elected as Fellow of the Royal Society

    26/07/2022

    We are making best hygiene solutions through Biotech applications: Dr Rachna Dave, founder MicroGO

  • Issues – Archives
  • Subscribe
  • Contact
Biotech Express
You are at:Home»Articles»Delhi High Court’s Sci-Hub Ban A Cruel Blow to Researchers, Victory for Predatory Publishers

Delhi High Court’s Sci-Hub Ban A Cruel Blow to Researchers, Victory for Predatory Publishers

0
By Biotech Express on 15/09/2025 Articles, Editorials

In December 2024, the Delhi High Court delivered a verdict that sent shockwaves through India’s academic community: Sci-Hub, the controversial platform that provided free access to millions of paywalled research articles, was banned. The ruling, championed by publishing giants like Elsevier, Wiley, and the American Chemical Society, was hailed as a victory for intellectual property. But for researchers, students, and academics across India—particularly those in underfunded institutions—it was a devastating blow to their pursuit of knowledge. The ban exposes a stark truth: academic publishers, with their billion-dollar profits, are not champions of science but gatekeepers who prioritize revenue over human progress.

For researchers like Anjali Sharma, a Ph.D. student at Jawaharlal Nehru University, Sci-Hub was more than a website—it was a lifeline. Anjali’s work on microbial resistance could one day help combat drug-resistant infections that plague India’s overcrowded hospitals. But her research hinges on accessing cutting-edge studies, many locked behind paywalls charging $30-$50 per article. With a monthly stipend of ₹25,000, barely enough for rent and food in Delhi, Anjali cannot afford these fees. Before the ban, Sci-Hub allowed her to download papers instantly, leveling the playing field in a world where knowledge is a luxury. Now, with the site blocked, her thesis hangs in the balance, and she’s not alone.

Across India, researchers in cash-strapped universities and institutes face the same struggle. Rohan Gupta, a physics postdoc at the Indian Institute of Science, relies on journal articles to stay competitive in a field where breakthroughs happen daily. “My department’s library budget was slashed last year,” he says. “Without Sci-Hub, I can’t access half the papers I need. How am I supposed to publish or teach?” Meera Patel, a medical researcher studying affordable TB treatments, echoes his frustration. “A single article costs more than a day’s wages for some of us,” she says. “These are studies that could save lives, but publishers want their profit first.”

The Delhi High Court’s decision stems from a lawsuit filed by Elsevier and others, who argued that Sci-Hub’s distribution of copyrighted articles undermines their business model. But what is this business model? Academic publishers like Elsevier, which reported over $1 billion in profits in 2024, thrive by exploiting a broken system. Researchers write papers for free, peer-review them for free, and often edit them for free. Publishers then package this labor into journals and charge exorbitant fees for access—fees that universities, libraries, and individuals must pay, often at the expense of other resources. In 2023, Elsevier’s parent company, RELX, boasted a 37% profit margin, far surpassing industries like tech or pharmaceuticals. This is not innovation; it’s profiteering.

The irony is galling. Publishers claim to advance science, yet their paywalls stifle the very researchers driving progress. In India, where public universities struggle with shrinking budgets and private institutions prioritize profit over scholarship, access to journals is a luxury few can afford. A single institutional subscription to a journal like Nature can cost lakhs of rupees annually, forcing libraries to pick and choose which fields get priority. Subjects like humanities or niche sciences often lose out, leaving researchers to fend for themselves. Sci-Hub, founded by Kazakhstani programmer Alexandra Elbakyan, emerged as a radical solution, offering free access to over 80 million articles. For scientists in the Global South, it was a beacon of hope in a system rigged against them.

The ban’s impact extends beyond academia. Anjali’s research could lead to treatments for infections that kill thousands in India each year. Meera’s work on TB could save lives in rural clinics. By blocking access to knowledge, publishers indirectly harm the public who rely on scientific advancements. The court’s ruling, while legally sound, ignores this human cost. Copyright law may protect publishers’ profits, but it does little to address the ethical question: why should knowledge, funded largely by public taxes and free academic labor, be locked behind paywalls?

On platforms like X, the #SciHubBan hashtag has sparked a global outcry. A Brazilian researcher posted, “I had to abandon a project because I couldn’t access key papers. Publishers don’t care about science—they care about money.” An Indian professor shared, “My students are rationing article downloads like food. This is what education looks like now.” These voices highlight a growing divide: publishers amass wealth while researchers, particularly in developing nations, are left scrambling.

Defenders of the publishers argue that producing journals requires significant costs—editing, hosting, and distribution aren’t free. But this argument crumbles under scrutiny. The bulk of editorial work is done by unpaid academics, and digital distribution costs are negligible in the age of the internet. Publishers’ high profit margins suggest they’re not struggling to stay afloat; they’re thriving by exploiting a captive market. Alternatives like open-access journals exist, but many require authors to pay hefty publication fees—often thousands of dollars—shifting the burden from readers to researchers, who are often equally cash-strapped.

The Sci-Hub ban is a symptom of a larger disease: a global academic system that prioritizes profit over progress. In India, where innovation is critical to addressing challenges like healthcare and climate change, restricting access to knowledge is a step backward. Researchers like Anjali, Rohan, and Meera deserve better. They’re not pirates; they’re scientists fighting for a better future. The Delhi High Court’s ruling may uphold the law, but it betrays the spirit of science. It’s time to rethink a system that lets publishers hold knowledge hostage while researchers—and the public—pay the price.

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Biotech Express
  • Website
  • Facebook
  • Twitter
  • LinkedIn

ISSN: 2454-6968 | Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports, Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology, Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurosciences, Genetics, Medical Sciences, BioPharma etc.

Related Posts

CDC Boss kicked out in RFK Jr.’s War on Corruption in pharma and healthcare

Prof. Rajeev Varshney FRS, now joins Australian Academy of Science

Dr. Cyrus S. Poonawalla, SII unveiled the newly built School for Hearing Impaired in Pune

Leave A Reply Cancel Reply

Current Issue – September 2025
Biotech Express – e-ISSN: 2454-6968

Editorial Board

For Authors – Article Submission and Guidelines

Peer Review Policies

License and Copyright

Advertisement

Recent Posts
  • CDC Boss kicked out in RFK Jr.’s War on Corruption in pharma and healthcare 21/09/2025
  • Prof. Rajeev Varshney FRS, now joins Australian Academy of Science 20/09/2025
  • Dr. Cyrus S. Poonawalla, SII unveiled the newly built School for Hearing Impaired in Pune 19/09/2025
  • AdFalciVax: ICMR’s New Malaria Vaccine: Hope or Premature Hype?” 18/09/2025
  • The Sudden Deaths and COVID Vaccines: A Critical Analysis of the ICMR and AIIMS Studies 17/09/2025
  • KGMU Scandal: Dr. Tulika Chandra Exposed in Crore Rupee Forgery and Scam 16/09/2025
  • Zydus to launch market-specific dosage variants of Semaglutide, MD says 15/09/2025
  • Biocon Biologics Launches Nepexto, Etanercept Biosimilar in Australia 15/09/2025
  • India launched its first National Biofoundry Network 15/09/2025
  • India has 94 Biotech Incubators across 25 states over 13 years 15/09/2025
Archives
Categories
  • Articles
  • Biotech News
  • Controversial
  • Editorials
  • Events
  • Featured
  • Guest Articles
  • Interviews
  • Interviews – Academia
  • Interviews – Industry
  • News-Industry
  • News-Research
  • Policies
  • SARS- CoV2 & COVID-19 Updates
  • Start-ups
About Us

About Biotech Express

Advisory and Editorial Board

Contact Us

Submission Policy and Guidelines

Submission policies

 

 

Follow us on Social Media
  • Facebook
  • Twitter
  • YouTube
We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies. Copyright © 2013-2025 Biotech Express except certain content provided by third parties.

Type above and press Enter to search. Press Esc to cancel.